中文网站
On November 20, the four-day “benchmark” event in the global medical technology sector—the MEDICA 2025 International Medical Devices Exhibition in Düsseldorf, Germany—successfully concluded. Hangzhou Bigfish Bio-Tech Co., Ltd. (hereinafter “Bigfish”) showcased its core diagnostic technologies and innovative product portfolio at the exhibition. On this top-tier platform, which gathered over 5,000 exhibitors from 72 countries and attracted 80,000 professional visitors worldwide, Bigfish engaged deeply with international peers, fully demonstrating the innovation strength and development vitality of China’s medical technology sector.
As the world’s largest and most influential B2B medical trade fair, MEDICA covers core areas across the medical industry chain, including medical imaging, laboratory technology, precision diagnostics, and health IT. It serves as a central hub for global medical professionals to gain insights into technological trends and facilitate international cooperation. This year’s exhibition centered on “Integration and Innovation of Precision Diagnostics and Smart Healthcare.” Bigfish closely aligned with industry hotspots, setting up a dedicated booth in the core exhibition area to showcase its breakthrough technologies and flagship products in in vitro diagnostics and molecular testing.
Bigfish Booth
At the exhibition, Bigfish highlighted its “Molecular Diagnostic Solutions,” consisting of nucleic acid extractors, PCR instruments, and real-time quantitative PCR machines, which became one of the most eye-catching product combinations. This product series has won international acclaim for four core advantages:
-
Highly Integrated Compact Design – breaking the size limitations of traditional equipment, it can be flexibly deployed in primary healthcare facilities, mobile testing vehicles, and other diverse scenarios.
-
Fully Automated Workflow – reducing manual operations by over 60%, which minimizes human error while significantly improving sample processing efficiency.
-
Intelligent Software System – offering “foolproof” operation with full-process visual guidance, enabling non-professionals to use it quickly.
-
Powerful Algorithm Analysis Module – providing precise analysis of test data, delivering reliable clinical decision support, with comprehensive performance indicators reaching international advanced standards.
Representatives from medical institutions and distributors across Europe, the Middle East, and Southeast Asia visited the booth, engaging in live demonstrations and technical discussions, giving high praise to the products’ innovation and practicality.
MEDICA provided Bigfish with a key bridge to the global medical market. Its highly integrated and intelligent product portfolio aligns precisely with the global demand for efficient diagnostic tools, which has become the company’s core advantage in attracting international partners.
During the exhibition, Bigfish reached preliminary cooperation intentions with several international partners, covering areas such as joint technology R&D and exclusive overseas agency agreements.
Through in-depth exchanges with top global experts, Bigfish gained a clearer understanding of international medical technology trends, providing crucial support for subsequent product iterations and global expansion.
Bigfish’s International Journey Steadily Advances
This exhibition marks not only a significant milestone for Bigfish in expanding its international market but also a vivid practice of Chinese biotech companies participating in global medical innovation collaboration.
Having focused on the field of bio-diagnostics for many years, Bigfish is committed to the mission of “empowering precision medicine through technological innovation.” Leveraging its independently developed core technology platforms, the company has launched multiple diagnostic products widely recognized in clinical practice domestically and internationally. This MEDICA debut signifies a further acceleration of Bigfish’s internationalization, bringing high-quality “Made-in-China” medical products and services to the global stage.
With the conclusion of MEDICA 2025, Bigfish has taken a solid step in its global journey.
In the future, the company will use this exhibition as an opportunity to deepen international cooperation, continue overcoming technological bottlenecks, and launch more innovative products tailored to global clinical needs, contributing Chinese expertise to enhance medical diagnostics worldwide and safeguard human health.
Post time: Nov-24-2025
Privacy settings